Clinical Trial Update: Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness [Phase 4]

View source ↗

Summary

Phase 4 trial update following participants from the original study to assess safety and effectiveness of glatiramer acetate (Copaxone) in relapsing-remitting m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2019-07-18